|Bid||5.26 x 60000|
|Ask||5.47 x 60000|
|Day's Range||5.26 - 5.26|
|52 Week Range||1.86 - 6.62|
|Beta (3Y Monthly)||0.17|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
The Los Angeles-based company said it had a loss of 24 cents per share. Losses, adjusted for one-time gains and costs, came to 14 cents per share. The digital ad exchange operator posted revenue of $32.4 ...
This is a nice win for this razor and razor-blade concern and helped drive a 15% rally in T2 Biosystems on Thursday. This trial combined the use of TG Therapeutics' compounds TG-1101 and TGR-1202 and Imbruvica to treat chronic lymphocytic leukemia or small lymphocytic lymphoma. After the bell Thursday, TG Therapeutics took advantage of the rally in the stock to initiate a raise of capital.
The Rubicon Project (RUBI) delivered earnings and revenue surprises of 21.74% and 2.76%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Los Angeles-based company said it had a loss of 27 cents. Losses, adjusted for non-recurring costs, came to 18 cents per share. The digital ad exchange operator posted revenue ...
The Rubicon Project (RUBI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If you’re interested in the Rubicon Project Inc (NYSE:RUBI), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stockRead More...
The Rubicon Project (RUBI) delivered earnings and revenue surprises of 6.90% and 2.83%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Los Angeles-based company said it had a loss of 36 cents per share. Losses, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to 27 cents per share. The digital ad ...
Google's delayed entry into a consortium of advertising technology companies has spoiled the members' push to comply with a new European privacy law, six people involved in the program told Reuters, leaving some firms exposed to fines. Most at risk are unwitting owners of ad-funded websites and apps, which Google has said have the responsibility of getting consent to serve targeted ads to European consumers. Data about a website visitor's identity can pass through a dozen ad tech firms before an ad is loaded, and each one must have user consent or another legal basis to access it under Europe's General Data Protection Regulation (GDPR).
Value stocks have been underperforming growth stocks and value investors have been hurting. According to Ken French’s calculations growth stocks outperformed value stocks by 16 percentage points since the beginning of 2017. Historically value stocks outperformed growth stocks by an average of about 5 percentage points per year, so the recent underperformance of value stocks […]
For months before European data-privacy laws came into effect, Google’s rivals fretted that the search giant was poised to benefit at their expense. Europe’s General Data Protection Regulation requires companies to gain consumer consent for data they collect and use, including the cookies that track where people go online and enable billions of dollars in targeted ads. Alphabet Inc.’s Google captured a larger share of European digital ad spending on May 25 after sowing doubt among some marketers about other providers.